Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check3 days agoChange DetectedThe study history now shows that the trial is no longer recruiting participants, and the record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check11 days agoChange Detected- An updated revision entry was added to the record history: Revision: v3.5.5. The previous entry Revision: v3.5.4 was removed, indicating a minor version-history update to the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry labeled v3.5.4 appears in the Record History, replacing the previous v3.5.3. This indicates a minor update to the page’s revision log rather than changes to the study data.SummaryDifference0.1%

- Check39 days agoChange DetectedIndiana University School of Medicine was replaced by Indiana University as the 'Information provided by' affiliation for the study record. This updates the institutional attribution and the responsible party associated with the study's information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s footer/site revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision v3.5.2 was added; Revision v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.